Pancreatitis-associated proteins: experimental and clinical studies

Citation
H. Paajanen et I. Nordback, Pancreatitis-associated proteins: experimental and clinical studies, ADDICT BIOL, 4(1), 1999, pp. 13-16
Citations number
27
Categorie Soggetti
Neurosciences & Behavoir
Journal title
ADDICTION BIOLOGY
ISSN journal
13556215 → ACNP
Volume
4
Issue
1
Year of publication
1999
Pages
13 - 16
Database
ISI
SICI code
1355-6215(199901)4:1<13:PPEACS>2.0.ZU;2-8
Abstract
Various novel biochemical markers indicate pancreatic cellular injury more accurately than serum amylase or lipase. One of these is a non-enzymatic se cretory protein called pancreatitis-associated protein (PAP). The main func tion of PAP is unclear at present but it may be an acute phase protein int he defence reactions of pancreatic cells. The protein was characterized in 1984 as a serum marker of pancreatitis. The serum PAP is expressed 6 hours after the induction of pancreatitis, and it increases to maximal levels wit hin 2-4 days: PAP is not sufficiently sensitive for the diagnosis of acute pancreatitis in the emergency room. The sensitivity and specificity of PAP in the differentiation of severe from mild pancreatitis is between 60-70%. This is not superior to serum CRP assays or CT scans. PAP increases in panc reatic cellular injury without pancreatitis (subclinical cell damage, graft rejection) where PAP may have a diagnostic role.